Trial of a Sustained Release Form of Amitriptyline (Lentizol) in the Treatment of Depressive Illness-Reference-Cited by-同舟云学术

Trial of a Sustained Release Form of Amitriptyline (Lentizol) in the Treatment of Depressive Illness

Published:1973-07 Issue:572 Volume:123 Page:69-71
ISSN:0007-1250
Container-title:British Journal of Psychiatry
language:en
Short-container-title:Br J Psychiatry

Author:

Sedman G.

Abstract

The advantages of a new sustained release form of amitriptyline (Lentizol) which can be given in a single dose for the treatment of depressive illness have recently been described by Sims (1972) and Haider (1972). This paper reports a similar double blind cross-over trial in the treatment of depressive illness (ICD 296) of the same substance compared against conventional amitriptyline at an overall higher dosage level.

Publisher

Royal College of Psychiatrists

Subject

Psychiatry and Mental health

Reference6 articles.

1. ‘Do psychiatric out-patients take their drugs?’;Wilcox;Brit. med. J.,1965

2. A Single Daily Dose of a New Form of Amitriptyline in Depressive Illness

3. An Inventory for Measuring Depression

4. Trial of a Sustained Release Form of Amitriptyline in the Treatment of Depressive Illness

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicomponent Crystals of Amitriptyline as Potential Controlled-Release Systems: Synthesis, Crystal Packing Analysis, and Dissolution Study;Crystal Growth & Design;2023-08-14

2. Antidepressants and Body Weight;The Journal of Clinical Psychiatry;2010-10-15

3. Antidepressants and weight gain;Appetite;1988-04

4. Weight gain;Journal of Affective Disorders;1984-10

5. Oral controlled release dosage forms. A review;Pharmaceutisch Weekblad;1984-04